{"nct_id":"NCT01034163","title":"A Phase III Randomized, Double Blind, Placebo Controlled Multi-center Study of Panobinostat for Maintenance of Response in Patients With Hodgkin's Lymphoma (HL)","status":"COMPLETED","status_verified_date":"2016-05","start_date":"2010-06","start_date_type":null,"primary_completion_date":"2012-05","primary_completion_date_type":"ACTUAL","completion_date":"2012-05","completion_date_type":"ACTUAL","phases":["PHASE3"],"tickers":["NVS"]}